In addition, upregulation of MEX3A was associated with shorter overall survival only in patients with HPV-negative cervical cancer, implying that MEX3A is not only related to the occurrence of HPV-negative cervical but also to prognosis of HPV-negative cervical cancer. The gene discussed is MEX3A; the disease is cervical cancer.